BridgeBio Pharma Inc (BBIO)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
12,818,475,000
EV to revenue ratio (TTM)
20.5
EV to ebitda
-9.4
Financial Performance
Revenue (TTM)
713,069,000
Gross profit (TTM)
673,414,000
EBITDA
-472,752,000
Profitability
Operating margin (TTM)
-43.90%
Profit margin
-97.00%
Return on assets (TTM)
-26.00%
Return on equity (TTM)
-1,790.00%
Per Share Metrics
Revenue per share (TTM)
3.68
EPS
-3.57
Diluted EPS (TTM)
-3.57
Book value
-12.88
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
17.98
Price to book ratio (TTM)
123.68
Growth
Quarterly earnings growth (YoY)
120.40%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
5
Buy
14
Hold
3
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.971